Ascendis Pharma A/S is a biopharmaceutical firm based in Hellerup, Denmark, founded in 2006. It specializes in creating innovative treatments for unmet medical needs, with a notable product, SKYTROFA, designed for individuals with growth hormone deficiency (GHD). Beyond SKYTROFA, Ascendis is actively working on a robust pipeline focused on rare endocrinology diseases and exploring new therapies in oncology.
Crinetics Pharmaceuticals (NASDAQ:CRNX) shares have climbed 99% just this week, from $42.03 at Monday’s close, to $83.54 earlier today. The simple reason: Vertex Pharmaceuticals (NASDAQ:VRTX | VRTX Price Prediction) agreed to acquire…
